Skip to main content
. 2018 Dec 4;20:267. doi: 10.1186/s13075-018-1771-0

Table 3.

Prevalence of comorbidities in limited or diffuse systemic sclerosis (SSc) and rheumatoid arthritis (RA) matched controls

Comorbidity Limited SSc
n = 182
RA
n = 182
OR Diffuse SSc
n = 226
RA
n = 226
OR
Diabetes mellitus 12 (6.6) 23 (12.6) 0.485 (0.234–1.007) 11 (4.8) 25 (11.1) 0.408 (0.195–0850)
Dyslipidemia 34 (18.7) 56 (30.8) 0.513 (0.315–0.836) 38 (16.7) 67 (29.6) 0.475 (0.303–0.745)
Arterial hypertension 56 (30.8) 54 (29.7) 1.04 (0.668–1.635) 75 (33.2) 71 (31.4) 1.084 (0.731–1.609)
Coronary event 4 (2.2) 6 (3.3) 0.655 (0.182–2.363) 7 (3.1) 9 (4.0) 0.764 (0.279–2.087)
Stroke 5 (2.7) 6 (3.3) 0.824 (0.247–2.749) 3 (1.3) 8 (3.5) 0.363 (0.095–1.387)
Ischemic 3 (1.6) 5 (2.7) 0.590 (0.139–2.506) 2 (0.9) 7 (3.1) 0.277 (0.057–1.347)
Hemorrhagic 2 (1.1) 1 (0.5) 2.00 (0.18–22.252) 1 (0.4) 1 (0.4) 0.991 (0.062–15.944)
Neoplasia 7 (3.8) 8 (4.4) 0.865 (0.307–2.437) 10 (4.4) 11 (4.9) 0.897 (0.373–2.155)
Chronic obstructive pulmonary disease 8 (4.4) 6 (3.3) 1.341 (0.456–3.945) 13 (5.7) 9 (4.0) 1.758 (0.610–3.482)
Osteoporosis 41 (22.4) 39 (21.4) 1.09 (0.79–1.50) 57 (25) 52 (23) 1.115 (0.725–1.716)
Depression 27 (14.8) 22 (12.1) 1.259 (0.688–2.304) 63 (27.6) 27 (11.9) 2.814 (1.714–4.620)